Intas Pharmaceutical Gets CDSCO Panels Nod to Conduct Phase III clinical trial of Ruxolitinib cream Dr. Divya Colin3 Nov 2024 5:00 PM ISTNew Delhi: Intas Pharmaceutical has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Ruxolitinib Cream Shows Promise in Treating Adolescent Atopic Dermatitis: Study Medha Baranwal10 May 2024 9:30 PM ISTUSA: In a groundbreaking development in dermatology, the efficacy, safety, and long-term disease control of Ruxolitinib Cream among adolescents with...
Ruxolitinib cream associated with higher repigmentation of vitiligo lesions, study says Medha Baranwal26 Oct 2022 8:00 PM ISTUSA: Results from two phase 3 trials published in the New England Journal of Medicine showed that the application of ruxolitinib cream led to a...
